Antibiotic therapy in dysentery of infectious etiology in early childhood: a systematic scoping review.

IF 0.6 Q4 PEDIATRICS
Juan F Guevara-Ramírez, Andrés F Rodríguez-Gutiérrez, Ingrid S Sánchez-Escobar, Samuel D Bolaños-Rodríguez, Valentina Adames-Restrepo, Simón A Ruiz-Galvis, Valentina Sánchez-Sánchez, Néstor A De La Cruz-Torres, Erwin H Hernández-Rincón, Samuel D Barbosa
{"title":"Antibiotic therapy in dysentery of infectious etiology in early childhood: a systematic scoping review.","authors":"Juan F Guevara-Ramírez, Andrés F Rodríguez-Gutiérrez, Ingrid S Sánchez-Escobar, Samuel D Bolaños-Rodríguez, Valentina Adames-Restrepo, Simón A Ruiz-Galvis, Valentina Sánchez-Sánchez, Néstor A De La Cruz-Torres, Erwin H Hernández-Rincón, Samuel D Barbosa","doi":"10.24875/BMHIM.24000085","DOIUrl":null,"url":null,"abstract":"<p><p>Acute diarrhea (AD) is one of the leading causes of child mortality, particularly in children under 5 years old. Dysentery, a severe form of AD characterized by blood and mucus in the stool, raises controversies regarding the appropriate use of antibiotics. The objective of this manuscript is to synthesize the available information on the indications, risks, and benefits of antibiotics used in infectious dysentery during early childhood. A scoping systematic review was conducted using international reference documents and the databases PubMed, Scopus, and Google Scholar, following the PRISMA-ScR guidelines. Studies from 2014 onwards that addressed antibiotic management in children under 5 years old with bacterial or parasitic dysentery were included. Among the 39 selected studies, the evidence shows limited benefits and significant risks associated with antibiotic use, with recommendations varying based on specific etiology and the patient's clinical conditions, where it is evident that the rational use of antibiotics in pediatric dysentery is crucial to avoid bacterial resistance and adverse effects. There is a need for future research to establish guidelines based on robust clinical trials, to optimize targeted treatment and improve clinical outcomes in this population.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"82 1","pages":"15-27"},"PeriodicalIF":0.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Boletín médico del Hospital Infantil de México","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/BMHIM.24000085","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Acute diarrhea (AD) is one of the leading causes of child mortality, particularly in children under 5 years old. Dysentery, a severe form of AD characterized by blood and mucus in the stool, raises controversies regarding the appropriate use of antibiotics. The objective of this manuscript is to synthesize the available information on the indications, risks, and benefits of antibiotics used in infectious dysentery during early childhood. A scoping systematic review was conducted using international reference documents and the databases PubMed, Scopus, and Google Scholar, following the PRISMA-ScR guidelines. Studies from 2014 onwards that addressed antibiotic management in children under 5 years old with bacterial or parasitic dysentery were included. Among the 39 selected studies, the evidence shows limited benefits and significant risks associated with antibiotic use, with recommendations varying based on specific etiology and the patient's clinical conditions, where it is evident that the rational use of antibiotics in pediatric dysentery is crucial to avoid bacterial resistance and adverse effects. There is a need for future research to establish guidelines based on robust clinical trials, to optimize targeted treatment and improve clinical outcomes in this population.

儿童早期感染性痢疾的抗生素治疗:一项系统的范围综述。
急性腹泻(AD)是儿童死亡的主要原因之一,特别是5岁以下儿童。痢疾是一种严重的阿尔茨海默病,其特征是粪便中有血和粘液,引起了关于抗生素适当使用的争议。这篇论文的目的是综合关于早期儿童感染性痢疾使用抗生素的适应症、风险和益处的现有信息。根据PRISMA-ScR指南,使用国际参考文献和PubMed、Scopus和谷歌Scholar数据库进行范围系统评价。从2014年起,对5岁以下患有细菌性或寄生性痢疾的儿童进行抗生素管理的研究被纳入其中。在选定的39项研究中,证据表明使用抗生素的益处有限,风险显著,建议根据具体病因和患者的临床情况有所不同,显然,在儿童痢疾中合理使用抗生素对于避免细菌耐药性和不良反应至关重要。未来的研究需要建立基于可靠临床试验的指南,以优化靶向治疗并改善这一人群的临床结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
73
审稿时长
20 weeks
期刊介绍: The Boletín Médico del Hospital Infantil de México is a bimonthly publication edited by the Hospital Infantil de México Federico Gómez. It receives unpublished manuscripts, in English or Spanish, relating to paediatrics in the following areas: biomedicine, clinical, public health, clinical epidemology, health education and clinical ethics. Articles can be original research articles, in-depth or systematic reviews, clinical cases, clinical-pathological cases, articles about public health, letters to the editor or editorials (by invitation).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信